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SUMMARY A brief overview of some metastatic carcinomas of 
the skin is given. The basic principles of the metastatic process, 
the distribution of metastases and clinical features of the most 
common metastatic carcinomas of the skin are presented, along 
with an account of our own data based on the records of Derma-
tohistology Registry of the University Department of Dermatol-
ogy and Venereology, Zagreb University Hospital Center, for the 
1994-2004 period and presentation of 22 cases of cutaneous 
metastases from this eleven-year period.
KEY WORDS: metastatic carcinoma of the skin, site of distant 
skin metastasis, type of skin metastasis
INTRODUCTION
 Metastasizing is defined as development of sec-
ondary implants (metastases) which are no longer 
in contact with primary tumor, and can be found 
in distant tissues. The ability to metastasize is the 
most important property of malignant tumors. Not 
all malignant tumors metastasize. Exceptions are 
basal cell carcinomas and some primary central 
nervous system tumors (1).
 Cutaneous metastases are defined as cancer 
involving the dermis or subcutaneous tissue that 
was not contiguous with the primary neoplasm (2). 
Malignant tumors spread into the skin per continu-
itatem, by lymphatic or hematogenous dissemina-
tion (1). Metastases to the skin can appear many 
years after extirpation of the primary tumor (3).
 In previous autopsy series the frequency of cu-
taneous metastases ranged from 0.7% to 4.4% 
(2,4-7), but a more recent study reports 9.0% (8). 
In previous reports, Lookingbill et al. have reported 
an overall frequency of 4.7% for skin metastases 
in patients with carcinoma, excluding melanoma 
(9). However, in a more recent study the same 
authors noted cutaneous metastases in 420 of 
4020 (10.4%) patients with metastatic disease (2). 
According to Braun Falco et al., between 3% and 
10% of cancer patients have cutaneous metasta-
ses (10).
The metastatic sequence
Metastatic process is very complex, and consists 
of several steps (11). Detachment from the pri-
mary tumor is the initial phase. It is believed that 
tumor cells are more easily separable from each 
other than normal ones. Invasion of tissue and in-
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travasation of vessel is very similar and proceeds 
in the following sequence: attachement to matrix 
or basement membrane receptors, secretion of 
hydrolytic enzymes to degrade the matrix, and fi-
nally movement of tumor cells into the region of 
degraded matrix. Upon entering the circulation, tu-
mor cell either remains and proliferates at the site 
of invasion and releases emboli, or detaches from 
the vessel wall and circulates. Once tumor cells 
enter the circulation, both hematogenous and lym-
phatic dissemination should be considered, due 
to extensive communications between blood and 
lymph vessels. 
 Whatever the distribution pattern, stasis of an 
embolic cell in the recipient tissue and extrava-
sation must occur. Extravasation and invasion of 
target organ consist of a sequence similar to that 
in intravasation (attachement to vessel wall, enzy-
matic degradation of vessel wall, and finally tumor 
cell moving out). The final step in the metastatic 
process is tumor cell proliferation in the recipient 
tissue. There are several mechanisms involved to 
enable successful proliferation: 1) presence of or-
gan specific growth factors, to which tumor cells 
are responsive; 2) increased or decreased sensi-
tivity of tumor cells to growth factors or growth in-
hibitors; 3) production of autocrine growth factors; 
and 4) production of angiogenic factors.
 Distribution of metastases
 There are three major distribution patterns in 
metastatic disease (11). The first one is mechani-
cal implantation, which accounts for 50%-60% of 
all cases. Multicellular emboli, which can be homo-
typic or heterotypic (includes not only tumor cells 
but also platelets, lymphocytes, etc.), are being ar-
rested in capillary bed due to their size. Examples 
of this type of distribution are head and neck can-
cers as well as melanoma, although melanoma 
also has a tendency to metastasize to specific 
organs such as lung, liver, brain, etc. Another dis-
tribution pattern is organ specific, which occurs via 
organ specific receptors on tumor cells, adhesion 
molecules, chemotaxis, or simply enhanced tumor 
cell proliferation within a given organ. Examples of 
nonspecific or random pattern of metastasizing are 
some highly aggressive metastatic tumors that are 
capable of adhering to vessel wall of many differ-
ent organs and proliferate in various tissues. Au-
tocrine growth factors are produced by tumor cells 
and provide a stimulus for cell growth and prolif-
eration regardless of the local environment, and 
local growth factors favor nonspecific metastases. 
 
 ETIOLOGY AND PATHOGENESIS
 Cutaneous metastasis may represent the first 
sign of a tumor, the first sign of tumor spread from 
its primary organ, or the first sign of recurrence 
of a cured tumor (10). The most common tumors 
are the most common sources of skin metasta-
ses. According to a retrospective study in 4020 
patients, performed by Lookingbill et al., the most 
common were skin metastases caused by mela-
noma, breast cancer, nasal sinus cancer, cancer 
of the larynx, endocrine gland cancer, oral cavity 
cancers, followed by esophageal cancer, urinary 
bladder cancer, cancer of unknown primary site, 
gallbladder and bile duct cancer, and liver cancer 
(2). Considering the origin of skin metastases ac-
cording to sex, the most common sources of skin 
metastases in men were melanoma, lung, colon 
and rectum cancer, oral cavity cancers, larynx, 
kidney, upper digestive tract, breast, nasal sinus, 
urinary bladder, esophagus, endocrine gland, 
stomach, pancreas and liver (2). In women, breast 
cancer was by far the most common primary site 
of skin metastasis, followed by melanoma, ovary, 
oral cavity, lung, colon and rectum, endometrium, 
urinary bladder, uterine cervix, stomach, bile duct, 
pancreas and endocrine glands (2). It was noted 
that tumor of unknown primary site was rather fre-
quently the source of skin metastases in both men 
and women.
TYPES OF SKIN METASTASES
 As noted by other investigators, most skin me-
tastases appear as nodules (12).The color differs 
and rarely provides useful diagnostic information. 
Melanoma metastases may be pigmented, while 
the ones originating from renal cell carcinoma are 
frequently red or purple, mimicking hemangiomas 
(13,14). Inflammatory skin metastases are most 
frequently caused by breast cancer (15). How-
ever, cancers from other sites can produce this 
type of metastases, such as cancer of the pan-
creas (16), rectum (2), lung (2), ovary (17), parotid 
glands (18) as well as melanoma (19). Cicatricial 
metastasis is usually caused by breast carcinoma, 
but may also arise from renal cell carcinoma. Bul-
lous lesions were described in some patients with 
breast cancer (2), and sometimes a zosterifom 
pattern of bullous distribution has been reported 
(20). Melanomatosis is seen in patients with ma-
lignant melanoma who have an increased produc-
tion of melanin that is spread hematogenously 
to all areas of the skin, resulting in slate-gray 
skin color as well as in urine discoloration (10). 
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Breast cancer
 Carcinoma of the breast is a common cancer 
in women, and may frequently involve the skin 
as well. According to some authors, 23.9% of pa-
tients with breast cancer have cutaneous metas-
tases (2). Also, the most interesting parts of his-
tory tackle breast carcinoma and its cutaneous 
involvement (21). So, Velpeau in 1838 described 
“cancer en cuirasse”, the name chosen because 
of the resemblance to the metal breastplate of a 
cuirassier (21). Paget described persistent breast 
eczema with breast cancer in 1874, and the dis-
order has been named after him (21).  In 1893, 
Hutchinson described carcinoma erysipelatoides 
(inflammatory metastatic carcinoma of the breast): 
“The erythematous infiltration of the skin was very 
superficial, and was attended simply by redness 
with a slight degree of induration. Until touched 
by the finger the condition might easily have been 
taken for a slightly-marked form of erysipelas, the 
spreading edge presenting much more vivid con-
gestion than the rest of the patch” (21). 
 Breast carcinoma shows eight different clinico-
pathologic types of skin involvement (22).
 Inflammatory metastatic carcinoma (car-
cinoma erysipelatoides). Superficial lymphatic 
metastases elicit an intense inflammatory re-
sponse mimicking erysipelas. There are irregular 
erythematous bands (10).
 Cancer en cuirasse shows a diffuse morhpea-
like induration of the skin. It is rarely seen in some 
other metastasizing malignancies such as lung, 
gastrointestinal tract, kidney, etc. (2,12,21-23). It 
usually begins as scattered, firm, lenticular papu-
lonodules overlying an erythematous or red-blue 
smooth cutaneous surface (22).
 Telangiectatic metastatic breast carcinoma 
presents with violaceous papulovesicles resem-
bling lymphangioma circumscriptum (21). 
 Nodular metastatic carcinoma usually ap-
pears as multiple papulonodules or nodules. 
Sometimes they may be solitary, rarely ulcerated 
or bullous (2,9,24-26).
 Alopecia neoplastica is caused by hema-
togenous rather than lymphatic spread, unlike 
the previously mentioned forms (21,27-30). It 
often presents as circular areas of alopecia like 
alopecia areata, is painless, nonpruritic, well-de-
marcated, of red-pink color with smooth surface 
(13). Since alopecia neoplastica might be the first 
sign of a metastatic breast cancer, breast exami-
nation and lesion biopsy should be performed in 
adult women showing this clinical picture (21). 
 
Table 1. Sites of distant skin metastases (modified from Lookingbill et al. (2))
Primary site Sites of distant skin metastases
Breast Back, scalp, upper extremities, abdomen, neck, shoulders, lower extremities, flank, chest*, 
buttocks, face
Melanoma Chest, lower extremities, upper extremities, neck, scalp, abdomen, back, face, shoulders, 
buttocks, flank, genitalia
Unknown Lower extremities, abdomen, neck, scalp, face, back, upper extremities, genitalia, flank, chest
Lung Chest, abdomen, scalp, neck, back, face, upper extremities, lower extremities
Oral cavity Neck, scalp, face, chest, back, upper extremities
Colon and 
rectum
Chest, back, abdomen, scalp, face, genitalia
Urinary bladder Chest, flank, abdomen
Ovary Abdomen, lower extremities
Larynx Chest, abdomen
Kidney Scalp, face, neck, chest, upper extremities
Esophagus Chest, abdomen, scalp, shoulders, upper extremities, lower extremities
Nasal sinuses Scalp, neck, back, abdomen




Uterine cervix Chest, abdomen, genitalia
Pancreas Chest, abdomen, upper extremities
Stomach Chest
*contralateral chest wall involvement without ipsilateral involvement; **site not specified in one 
162
Ledić Drvar et al.:   Acta Dermatovenerol Croat
Eleven-year retrospective study of metastatic carcinomas of the skin  2005;13(3):160-167
ACTA DERMATOVENEROLOGICA CROATICA
 Paget’s disease is a sharply demarcated ec-
zema on the nipple or areola, usually but not al-
ways associated with underlying breast cancer 
(21). Nipple biopsy should be obtained in a woman 
with a history suspect of Paget’s disease, because 
the cured Paget’s disease still indicates underly-
ing breast cancer (21,31).              
Breast carcinoma of the inframammary crease 
is characterized by a cutaneous exophytic nodule 
resembling primary cutaneous squamous or basal 
cell carcinoma (32,33). 
Metastatic mammary carcinoma of the eyelid 
with histiocytoid histology (21) appears as pain-
less eyelid swelling with induration, or as a nodule. 
 Melanoma
 Melanoma is the third most common cause of 
skin metastases (24). They are usually heavily 
pigmented, although there are cases of amelanot-
ic ones, too. They present as a few or showers of 
nodules (21).
Renal cell carcinoma
 Very often skin metastases are the first sign 
of renal cell carinoma (13,34) but they may also 
appear 10 years after the initial cancer diagno-
sis (35). The metastases appear as well-circum-
scribed nodules of flesh-, violaceous, or blue-col-
ored, but also as a cutaneous horn (34,36).   
Carcinoma of the lung
 Skin metastases may appear, as a localized 
cluster of cutaneous nodules, on any cutaneous 
surface, although the most common sites are the 
chest wall and posterior abdomen. Oat cell carci-
noma of the lung usually metastasizes to the skin 
of the back (2,21).
Sister Mary Joseph nodule
 Sister Mary Joseph was an operating room 
nurse at The Mayo Clinic. She was the first one 
to report that patients with umbilical nodule she 
noticed during preparation for surgery usually 
had intra-abdominal metastases. Some tumors of 
the gastrointestinal system (stomach, colon and 
pancreas) may give metastases to the umbilicus 
(10).   
HISTOPATHOLOGY
 Histologic pattern in cutaneous metastatic dis-
ease may be specific or nonspecific. Some clini-
cal and histologic features may indicate a primary 
tumor. Specific histologic stains as well as the use 
of immunohistochemistry and electron microscopy 
techniques are enormously helpful in the diagno-
sis of cutanous metastatic diseases (37).  
 
Table 1. Sites of distant skin metastases (modified from Lookingbill et al. (2))
Primary site Sites of distant skin metastases
Breast Back, scalp, upper extremities, abdomen, neck, shoulders, lower extremities, flank, chest*, 
buttocks, face
Melanoma Chest, lower extremities, upper extremities, neck, scalp, abdomen, back, face, shoulders, 
buttocks, flank, genitalia
Unknown Lower extremities, abdomen, neck, scalp, face, back, upper extremities, genitalia, flank, chest
Lung Chest, abdomen, scalp, neck, back, face, upper extremities, lower extremities
Oral cavity Neck, scalp, face, chest, back, upper extremities
Colon and 
rectum
Chest, back, abdomen, scalp, face, genitalia
Urinary bladder Chest, flank, abdomen
Ovary Abdomen, lower extremities
Larynx Chest, abdomen
Kidney Scalp, face, neck, chest, upper extremities
Esophagus Chest, abdomen, scalp, shoulders, upper extremities, lower extremities
Nasal sinuses Scalp, neck, back, abdomen




Uterine cervix Chest, abdomen, genitalia
Pancreas Chest, abdomen, upper extremities
Stomach Chest
*contralateral chest wall involvement without ipsilateral involvement; **site not specified in one 
Figure 1. Alopecia neoplastica in a patient with 
breast cancer.
Figure 1a. Histopathology of the same patient. 
The tumor cells form small groups of single rows 
between fibrotic and thickened collagen bundles. 
(H&E, x75)
Figure 2. Cutaneous metastases in a patient with 
renal cell carcinoma.
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DIFFERENTIAL DIAGNOSIS
 As discussed under clinical appearance, skin 
metastases may mimic a wide variety of disorders 
such as erysipelas, alopecia areata, eczema, vari-
ous primary carcinoma cutis, etc. Careful exami-
nation and thorough patient history should be un-
dertaken to avoid misdiagnosis.
TREATMENT
 Depending on the type of tumor, symptoms, 
and degree of tumor burden, treatment options in-
clude chemotherapy, radiotherapy, and excision. 
Cutaneous metastases can serve as a marker of 
response to systemic therapy (38). The presence 
of cutaneous metastases usually urges the need 
of change in therapy for primary tumor.
COURSE AND PROGNOSIS
 Skin metastases represent a poor prognostic 
sign, especially in patients suffering from cancers 
of the lung, ovary, upper respiratory tract or upper 
digestive tract (2).
 PRESENTATION OF 22 PATIENTS WITH 
METASTATIC CARCINOMAS OF THE SKIN 
1994-2004: OWN DATA
 Twenty-two patients with histologically veri-
fied diagnosis of metastatic skin disease were re-
corded at our Department during the 1994-2004 
period. There were five men and 17 women, age 
range 46-84 in men and 42-88 in women. In men, 
the primary tumor site was lung in 2 cases, where-
as in the remaining three cases primary tumor 
was unknown at the time of histologic diagnosis 
(Table 2). In women, breast cancer was by far the 
most common cause of skin metastases (n=12), in 
three cases the primary site was unknown, where-
as malignant melanoma and primary gynecologic 
tumor were found in one case each (Table 3).
As for clinical manifestations, metastases of lung 
cancer appeared as noduli located on the abdo-
men, back, and extremities. Cutaneous metasta-
ses of breast cancer appeared as carcinoma en 
cuirasse, carcinoma erysipelatoides, cicatricial 
alopecia (Fig. 1), different types of noduli and 
papules, erythema, exanthema and edema. Car-
cinoma of the ovary presented as tumorous le-
sions in the region of abdominal wall and thorax 
(Fig. 3). Malignant melanoma skin metastases 
showed a clinical picture of elephantiasis of the 
extremity, with erythematous, papular infiltrate. 
Figure 3. Breast carcinoma metastatic to the 
skin – histopathology. Diluted lymphatics contain 
groups of tumor cells. (H&E, x40) 
Figure 4. Cutaneous metastases in a patient with 
primary carcinoma of the ovary.
Figure 4a. Tumor tissue consists of atypical 
glandular formations which are covered by atypical 
cylindric epithelial cells. (H&E, x75)
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 CONCLUSIONS
 Dermatologists are nowadays encountering cu-
tanous metastases not only from primary melano-
mas and squamous cell carcinomas but also from 
other cancers giving rise to skin metastases. Ac-
cording to recent literature, between 3% and 10% 
of cancer patients have cutaneous metastases. We 
report on 22 patients with metastatic skin disease 
during a 11-year period (1994-2004). The incidence 
of various tumors that are metastatic to the skin 
correlated well with the prevalence of primary ma-
lignant tumors in each sex. Breast cancer was most 
common in women and lung cancer in men.  
Patient No. Age (yrs) Sex Primary tumor Metastasis
1 61 M Unknown Abdominal noduli
2 66 M Unknown, bone metastasis, 
right axilar metastasis, 
abdominal tumorous infiltrates 
in which malignant cells were 
cytologically verified 
Scalp – 3 infiltrated lesions, with central erosions and 
crusts
3 84 M Unknown Umbilical and periumbilical red elevated lesions, 
crusted
4 46 M Carcinoma pulmonum Abdominal noduli, with lymph discharge, 2 infiltrates 
on the back
5 68 M Carcinoma pulmonum Brown-livid noduli on left thigh, left forearm and right 
hand
6 59 F Carcinoma mammae Papulous exanthema under right breast, and on the 
right side of abdomen. Carcinoma en cuirasse in obs.     
7 60 F Unknown Edema of right breast and neighboring parts of the 
chest wall as well as of complete right arm. Skin is red, 
there are scattered groups of herpetiform vesicles
8 74 F Carcinoma mammae Small noduli in the scar area
9 50 F Carcinoma mammae Dermatitis papulosa
10 88 F Unknown Hand tumors
11 87 F Carcinoma mammae Papule on the back
12 67 F Carcinoma mammae Erythema in the scar region, on the sternum
13 59 F Carcinoma mammae Infiltratio regionalis mammae l. sin. and mammae dex.
14 46 F Carcinoma mammae Livid tumorous lesion above scar, with  vesicles of 
pinpoint size on the surface. On the back annular 
lesions with elevated edge
15 45 F Carcinoma ovarii 
metastaticum, primary tumor 
unknown
Lymphoedema of both legs. Erythematous-livid 
infiltrate in pubic area 
16 65 F Carcinoma mammae Trophic ulcer on the left side of the back
17 71 F Melanoma malignum Elephantiasis of the left leg, indurated erythematous, 
edematous infiltrate with papuli
18 63 F Adenoacanthoma endometrii, 
Adenocarcinoma ovarii
Tumorous lesions in the region of abdominal wall and 
thorax. Some lesions of walnut size are exulcerated
19 61 F Unknown, histologically: 
Carcinoma mammae
Several white-yellowish halph-sphere lesions up to a 
pea size in the scalp 
20 47 F Carcinoma mammae Carcinoma erysipelatoides mammae l. sin.
21 42 F Carcinoma mammae Noduli in the scalp, nuchal area as well as in the right 
labium majus
22 45 F Carcinoma mammae Cicatricial alopecia in the occipital region
Figure 4b. Detail, (H&E, x100)
Table 2. Cutaneous metastases in our patients
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